Use of high-dose oxazaphosphorine drugs for treating immune disorders
作者： Robert A. Brodsky , Richard J. Jones
DOI:
关键词:
摘要: This disclosure relates, at least in part, to methods of eliminating adverse immune reactions a subject need thereof including those associated with autoimmune diseases, allergic and transplant rejection, administration lymphocytotoxic non-myeloablative amount oxazaphosphorine drug the subject.
lens.org 参考文章(50)
Alessandro M. Gianni, Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both ,(1995)
Roger Pomerantz, Method of treating residual HIV-I disease ,(2001)
Lee Walters, Applications of immune system tolerance to treatment of various diseases ,(2001)
Yugiang Wang, David Farquhar, Antitumor aldophosphamide glycoside and dideoxyuridine derivatives ,(1992)
Bert L. Vallee, Wing Ming Keung, Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse ,(1992)
Bert L. Vallee, Wing Ming Keung, Guangyao Gao, Compounds useful for the inhibition of aldh ,(2003)
William E. Fahl, John A. Kink, Ming Zhu, Nalini Raghavachari, Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy ,(2001)
Scott Lukas, David Yue-We Lee, Method for treating alcohol intoxication and alcohol abuse ,(2001)